Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $489.61 ($4.7M) on 2026-09-22, disclosed to the SEC on 2026-09-23.
Scheduled sale ($4.7M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $489.61 | 240 | $118K | 2.5% |
| 2 | $490.54 | 424 | $208K | 4.4% |
| 3 | $491.45 | 736 | $362K | 7.7% |
| 4 | $492.67 | 628 | $309K | 6.6% |
| 5 | $493.70 | 1,645 | $812K | 17.3% |
| 6 | $494.66 | 1,337 |
| $661K |
| 14.1% |
| 7 | $495.77 | 1,488 | $738K | 15.7% |
| 8 | $496.83 | 1,484 | $737K | 15.7% |
| 9 | $497.73 | 1,358 | $676K | 14.4% |
| 10 | $499.07 | 160 | $80K | 1.7% |
| Total | $494.83 avg | 9,500 | $4.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-07 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-06 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-05 | $5.2M | — | Filing → |